[ Price : $8.95]
Federal Register notice: FDA determines that 20 listed drug products were not withdrawn from sale due to safety or effectiveness i...[ Price : $8.95]
FDA issues a clinical hold against Tryp Therapeutics and a Phase 2a study evaluating its psilocybin for eating disorders.[ Price : $8.95]
Agenus withdraws a BLA for balstilimab after FDA urged it to do so following Mercks recent full approval for pembrolizumab for tre...[ Price : $8.95]
FDA approves Biofronteras BF-RhodoLED XL, a red-light source for photodynamic therapy and its combination use with the companys Am...[ Price : $8.95]
FDA approves Genentechs Susvimo (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant for treating certain peo...[ Price : $8.95]
Federal Register notice: FDA withdraws the approval of 216 ANDAs from multiple holders because they repeatedly failed to submit re...[ Price : $8.95]
President Biden meets with potential FDA commissioner nominee Robert Califf in what may be the last step before an official announ...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Orion Corp.s Nubeqa (darolu...